SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
31-Mar-21 12:30 PM View: | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 8,385 | -- | -- | (100%) 8.38K to 0 | |
19-Mar-21 5:36 PM View: | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 23,453 | -- | -- | (100%) 23.45K to 0 | |
12-Jan-21 7:02 PM View: | Urovant Sciences Ltd. (UROV) | 10-Jan-21 | Payment of Exercise | 4,095 | $16.11 | $65,970.50 | (33%) 12.48K to 8.38K | (< 1%) |
11-Jun-20 8:23 PM View: | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 100% 0 to 23.45K | |
14-Jan-20 4:09 PM View: | Urovant Sciences Ltd. (UROV) | 10-Jan-20 | Grant | 12,480 | -- | -- | 100% 0 to 12.48K | |
05-Apr-19 5:10 PM View: | Alkermes Plc. (ALKS) | 04-Apr-19 | Payment of Exercise | 1,838 | $35.89 | $65,965.80 | (29%) 6.25K to 4.41K | 40% |
05-Apr-19 5:10 PM View: | Alkermes Plc. (ALKS) | 04-Apr-19 | Option Exercise | 6,250 | -- | -- | 100% 0 to 6.25K |